Since AChE-R mRNA levels were very low compared to those of the major AChE-S transcript, both the total levels of catalytically active AChE and the levels of its transcripts were lower in the AD brains compared to controls (Figures 3A,C). This evidence concerns the gene ACHE and Alzheimer disease.